| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 102.465 | 0 | 52.145 | 726 | 3.219 | 3.104 | - | - | - | - |
| Total Income - EUR | 102.465 | 0 | 52.145 | 726 | 3.219 | 3.104 | - | - | - | - |
| Total Expenses - EUR | 97.252 | 0 | 47.466 | 14.265 | 4.586 | 6.106 | - | - | - | - |
| Gross Profit/Loss - EUR | 5.213 | 0 | 4.679 | -13.539 | -1.367 | -3.002 | - | - | - | - |
| Net Profit/Loss - EUR | 5.213 | 0 | 3.553 | -13.561 | -1.464 | -3.097 | - | - | - | - |
| Employees | 6 | 0 | 5 | 0 | 0 | 0 | - | - | - | - |
Check the financial reports for the company - Opti Sanomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 191 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Current Assets | 20.071 | 0 | 28.495 | 7.598 | 4.038 | 939 | - | - | - | - |
| Inventories | 10.472 | 0 | 15.730 | 0 | 0 | 0 | - | - | - | - |
| Receivables | 11.730 | 0 | 12.006 | 7.542 | 4.029 | 0 | - | - | - | - |
| Cash | -2.131 | 0 | 760 | 55 | 8 | 939 | - | - | - | - |
| Shareholders Funds | -2.938 | 0 | 5.682 | -7.983 | -9.292 | -12.213 | - | - | - | - |
| Social Capital | 45 | 0 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 23.723 | 0 | 23.306 | 16.064 | 13.804 | 13.153 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4775 - 4775" | |||||||||
| CAEN Financial Year |
4775
|
|||||||||
Comments - Opti Sanomed Srl